179 related articles for article (PubMed ID: 6102792)
1. Neuroleptic plasma levels and tardive dyskinesia: a possible link?
Nasrallah HA
Schizophr Bull; 1980; 6(1):4-7. PubMed ID: 6102792
[TBL] [Abstract][Full Text] [Related]
2. The effect of neuroleptic discontinuation on psychopathology, involuntary movements, and biochemical measures in patients with persistent tardive dyskinesia.
Glazer WM; Bowers MB; Charney DS; Heninger GR
Biol Psychiatry; 1989 Jul; 26(3):224-33. PubMed ID: 2568132
[TBL] [Abstract][Full Text] [Related]
3. Normal prolactin responses in tardive dyskinesia.
Asnis GM; Sachar EJ; Langer G; Halpern FS; Fink M
Psychopharmacology (Berl); 1979; 66(3):247-50. PubMed ID: 43550
[TBL] [Abstract][Full Text] [Related]
4. Intermittent neuroleptic therapy and tardive dyskinesia: a literature review.
Goldman MB; Luchins DJ
Hosp Community Psychiatry; 1984 Dec; 35(12):1215-9. PubMed ID: 6150891
[TBL] [Abstract][Full Text] [Related]
5. Neuroleptic plasma levels and tardive dyskinesia.
Giller E
Schizophr Bull; 1980; 6(3):391-2. PubMed ID: 6105706
[No Abstract] [Full Text] [Related]
6. Possible associations among plasma prolactin levels, tardive dyskinesia, and paranoia in treated male schizophrenics.
Csernansky JG; Prosser E; Kaplan J; Mahler E; Berger PA; Hollister LE
Biol Psychiatry; 1986 Jun; 21(7):632-42. PubMed ID: 2871874
[TBL] [Abstract][Full Text] [Related]
7. Serum neuroleptic activity, prolactin, and tardive dyskinesia in schizophrenic outpatients.
Csernansky JG; Kaplan J; Holman CA; Hollister LE
Psychopharmacology (Berl); 1983; 81(2):115-8. PubMed ID: 6138793
[TBL] [Abstract][Full Text] [Related]
8. Plasma amine metabolites before and after withdrawal from neuroleptic treatment in chronic schizophrenic inpatients.
Kirch DG; Jaskiw G; Linnoila M; Weinberger DR; Wyatt RJ
Psychiatry Res; 1988 Sep; 25(3):233-42. PubMed ID: 2903509
[TBL] [Abstract][Full Text] [Related]
9. Serum-soluble interleukin-2 receptors in neuroleptic-naive schizophrenic subjects and in medicated schizophrenic subjects with and without tardive dyskinesia.
Rapaport MH; Lohr JB
Acta Psychiatr Scand; 1994 Nov; 90(5):311-5. PubMed ID: 7872033
[TBL] [Abstract][Full Text] [Related]
10. Alterations in sleep polygraphy after neuroleptic withdrawal: a putative supersensitive dopaminergic mechanism.
Thaker GK; Wagman AM; Kirkpatrick B; Tamminga CA
Biol Psychiatry; 1989 Jan; 25(1):75-86. PubMed ID: 2563233
[TBL] [Abstract][Full Text] [Related]
11. Long term treatment of tardive dyskinesia.
Jus A; Jus K; Fontaine P
J Clin Psychiatry; 1979 Feb; 40(2):72-7. PubMed ID: 33156
[TBL] [Abstract][Full Text] [Related]
12. Managing tardive dyskinesia.
Casey DE
J Clin Psychiatry; 1978 Oct; 39(10):748-53. PubMed ID: 30759
[TBL] [Abstract][Full Text] [Related]
13. Tardive dyskinesia and steady-state serum levels of thiothixene.
Yesavage JA; Tanke ED; Sheikh JI
Arch Gen Psychiatry; 1987 Oct; 44(10):913-5. PubMed ID: 2889439
[TBL] [Abstract][Full Text] [Related]
14. Clinical relationship of extrapyramidal symptoms and tardive dyskinesia.
Andrew HG
Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S76-80. PubMed ID: 7874668
[TBL] [Abstract][Full Text] [Related]
15. Effect of neuroleptic withdrawal on plasma prolactin: a possible marker of receptor adaptation.
Kirkpatrick B; Buchanan RW; Maeda K; Carpenter WT; Jauch D; Tamminga CA
Biol Psychiatry; 1989 Jun; 26(2):131-8. PubMed ID: 2567610
[TBL] [Abstract][Full Text] [Related]
16. The treatment of tardive dyskinesia.
Raja M
Schweiz Arch Neurol Psychiatr (1985); 1996; 147(1):13-8. PubMed ID: 8685689
[TBL] [Abstract][Full Text] [Related]
17. Clinical predictors of relapse following neuroleptic withdrawal.
Buchanan RW; Kirkpatrick B; Summerfelt A; Hanlon TE; Levine J; Carpenter WT
Biol Psychiatry; 1992 Jul; 32(1):72-8. PubMed ID: 1356490
[TBL] [Abstract][Full Text] [Related]
18. Tardive dyskinesia: clinical, biological, and pharmacological perspectives.
Berger PA; Rexroth K
Schizophr Bull; 1980; 6(1):102-16. PubMed ID: 6102788
[TBL] [Abstract][Full Text] [Related]
19. An update on tardive dyskinesia.
Simpson GM; Pi EH; Sramek JJ
Hosp Community Psychiatry; 1986 Apr; 37(4):362-9. PubMed ID: 2870977
[TBL] [Abstract][Full Text] [Related]
20. Plasma homovanillic acid and tardive dyskinesia during neuroleptic maintenance and withdrawal.
Kirch D; Hattox S; Bell J; Murphy R; Freedman R
Psychiatry Res; 1983 Jul; 9(3):217-23. PubMed ID: 6137850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
